L:NYSELoews Corporation Analysis
Data as of 2026-03-11 - not real-time
$109.16
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Loews Corp (L) is trading at $109.16, just below its DCF‑derived fair value of $110.70, suggesting a modest undervaluation. The stock sits above its 50‑day SMA ($107.01) but slightly under the 20‑day SMA ($109.81), indicating a near‑term pull‑back within an overall bullish trend. Technical momentum is mixed: RSI is neutral at 51, while the MACD histogram is negative and the signal line is bearish, warning of short‑term downside pressure. Volume remains stable and the price is holding just above the identified support of $107.48, with resistance near $112.32. Fundamentally, L delivers a P/E of 13.7 versus an industry average of 17.3, a price‑to‑book of 1.20 and a dividend yield of 0.23% backed by a tiny payout ratio of 3%. The balance sheet shows ample cash ($7.2 B) against debt ($9.9 B) and a debt‑to‑equity of 50%, supporting dividend sustainability.
Given the low beta of 0.53 and 30‑day volatility of ~15.6%, the stock exhibits lower market risk than many peers, while the insurance‑centric sector carries medium regulatory exposure. The company’s modest 4.1% revenue growth, solid operating cash flow ($3.28 B) and free cash flow ($1.54 B) provide a sturdy foundation for continued dividend payments. Overall, the blend of modest undervaluation, strong cash generation and defensive risk profile points to a favorable outlook across medium and long horizons. Investors should monitor the MACD crossover for any near‑term weakness but can consider accumulation as the price re‑approaches its fair value.
Given the low beta of 0.53 and 30‑day volatility of ~15.6%, the stock exhibits lower market risk than many peers, while the insurance‑centric sector carries medium regulatory exposure. The company’s modest 4.1% revenue growth, solid operating cash flow ($3.28 B) and free cash flow ($1.54 B) provide a sturdy foundation for continued dividend payments. Overall, the blend of modest undervaluation, strong cash generation and defensive risk profile points to a favorable outlook across medium and long horizons. Investors should monitor the MACD crossover for any near‑term weakness but can consider accumulation as the price re‑approaches its fair value.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near support at $107.48
- bearish MACD histogram
- stable volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- undervalued relative to DCF and industry P/E
- strong operating cash flow
- low payout ratio supporting dividend
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- diversified holding structure across insurance, energy, hotels
- low beta and defensive risk profile
- sustainable dividend backed by cash reserves
Key Metrics & Analysis
Financial Health
Revenue Growth4.10%
Profit Margin9.03%
P/E Ratio13.7
ROE9.43%
ROA1.97%
Debt/Equity50.22
P/B Ratio1.2
Op. Cash Flow$3.3B
Free Cash Flow$1.5B
Industry P/E17.3
Technical Analysis
TrendBullish
RSI50.9
Support$107.48
Resistance$112.32
MA 20$109.81
MA 50$107.01
MA 200$99.50
MACDBearish
VolumeStable
Fear & Greed Index76.91
Valuation
Fair Value$110.70
GradeUndervalued
TypeValue
Dividend Yield0.23%
Risk Assessment
Beta0.53
Volatility15.58%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.